Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Teva
Healthtrust
Fish and Richardson
Moodys
Chinese Patent Office
US Department of Justice
Fuji
Cipla

Generated: June 18, 2018

DrugPatentWatch Database Preview

APOKYN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Apokyn, and when can generic versions of Apokyn launch?

Apokyn is a drug marketed by Us Worldmeds and is included in one NDA.

The generic ingredient in APOKYN is apomorphine hydrochloride. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the apomorphine hydrochloride profile page.
Drug patent expirations by year for APOKYN
Pharmacology for APOKYN
Drug ClassDopaminergic Agonist
Mechanism of ActionDopamine Agonists
Medical Subject Heading (MeSH) Categories for APOKYN
Synonyms for APOKYN
(-)-10,11-Dihydroxyaporphine
(-)-Apomorphine
(-)-Apomorphine (hydrochloride)
(-)-Apomorphine hydrochloride
(-)-Apomorphinium hydrochloride
(-)6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol(APO)
(6aR)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo(de,g)chinolin-10,11-diol
(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol
(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol hydrochloride
(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol;hydrate;hydrochloride
(9R)-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2,4,6,13,15-hexaene-3,4-diol
(9R)-10-methyl-10-azatetracyclo[7.7.1.0;{2,7}.0;{13,17}]heptadeca-1(16),2(7),3,5,13(17),14-hexaene-3,4-diol
(Apomorphine) 6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol
(apomorphine)6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol
(R)-(-)-Apomorphine
(R)-(-)-apomorphine HCl
(R)-(-)-Apomorphine hydrochloride
(R)-5,6,6A,7-TETRAHYDRO-6-METHYL-4H-DIBENZO[DE-G]QUINOLINE-10,11-DIOL
(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol hydrochloride
(R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol
(R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol ((R)-apomorphine)
(R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol (apomorphine)
(R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol(apomorphine)
(R)-Apomorphine
314-19-2
314-19-2 (hydrochloride anhydrous)
372A207
41372-20-7
41372-20-7 (hydrochloride hemihydrate)
4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, (R)-
4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, (R)- (9CI)
4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, hydrochloride (1:1), (6aR)-
4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, hydrochloride, (6aR)-
4H-Dibenzo[de,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, hydrochloride, (R)-
5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo(de,g)chinolin-10,11-diol hydrochlorid
58-00-4
58-00-4 (Parent)
5896-07-1
6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol ((R)-apomorphine)
6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol((R)-apomorphine)
6a-beta-Aporphine-10,11-diol
6a-beta-Aporphine-10,11-diol, hydrochloride
6a-beta-Noraporphine-10,11-diol, 6-methyl-, hydrochloride
6a.beta.-Aporphine-10, hydrochloride
6a.beta.-Noraporphine-10, 6-methyl-, hydrochloride
6abeta-Aporphine-10,11-diol
6abeta-Aporphine-10,11-diol, hydrochloride
6abeta-Aporphine-10,11-diol, hydrochloride (8CI)
6abeta-Noraporphine-10,11-diol, 6-methyl-, hydrochloride
8233AH
9K13MD7A0D
AC1L1LLC
AC1L1SZ7
AC1Q3F8P
AKOS024456928
API0001523
Apomorfin
Apomorphin
Apomorphin hydrochlorid
apomorphine
Apomorphine (BAN)
Apomorphine (intranasal, Parkinson's disease)
Apomorphine (R,-)
Apomorphine [BAN]
Apomorphine chloride
Apomorphine HCl
Apomorphine hydrochloride
Apomorphine Hydrochloride (anhydrous)
Apomorphine hydrochloride (R,-)
Apomorphine hydrochloride anhydrous
Apomorphine hydrochloride hemihydrate
Apomorphine hydrochloride hydrate
Apomorphine Hydrochloride, Anhydrous
Apomorphine SL
apomorphine-hcl
APOMORPHINE, HYDROCHLORIDE
APOMORPHINE6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol
APOMORPHINEHYDROCHLORIDE
Apomorphinium chloride
Apomorphinium chloride hemihydrate
Apomorphinum hydrochloricum
Apormorphine
B6936
BB_NC-0484
BDBM29644
BDBM50001955
BG0043
Biomol-NT_000019
BPBio1_000092
BPBio1_001179
BRD-K76022557-001-01-3
BRD-K76022557-311-20-6
BSPBio_000082
C17H17NO2
C17H17NO2.HCl
CAS-58-00-4
CHEBI:48538
CHEMBL1616
CHEMBL53
cid_6852399
CTK8F2000
D07460
D0B6QP
D0H6QU
DB00714
DSSTox_CID_2614
DSSTox_GSID_22614
DSSTox_RID_76660
DTXSID5040598
DTXSID8022614
EINECS 200-360-0
EINECS 206-243-0
FT-0602881
GTPL33
H72A207
HMS2089C10
HSDB 3289
IV Apomorphine
Ixense
J-018414
L-Apomorphine
LS-21474
LS-61218
MCULE-1576765478
MCULE-3200317958
MolPort-003-983-404
N-Methylnorapomorphine hydrochloride
N21FAR7B4S
NCGC00025349-01
NCGC00025349-02
NCGC00025349-03
NCGC00025349-04
NCGC00025349-05
NH001
NSC 11442
NSC-11442
NSC11442
PDSP1_000780
PDSP2_001488
pomorphini hydrochloridum
Prestwick_28
Prestwick0_000101
Prestwick1_000101
Prestwick2_000101
Prestwick3_000101
Q-200645
R-(-)-Apomorphine
R-(-)-apomorphine HCl
R-(-)-Apomorphine hydrochloride
R( C)-10,11- paragraph signthornoC>>u degrees centAEO.E
R( C)-APO
SCHEMBL8524
SCHEMBL8541
SKYZYDSNJIOXRL-BTQNPOSSSA-N
SMP1_000027
SPBio_002021
SR-01000597777
SR-01000597777-1
STOCK1N-03149
Tocris-2073
Tox21_110967
Tox21_110967_1
UNII-9K13MD7A0D
UNII-N21FAR7B4S
Uprima
Uprima (TN)
VMWNQDUVQKEIOC-CYBMUJFWSA-N
VR-040
VR-400
VR004
WLN: T C6666 1A Q KN & TT & J DQ EQ K1 & GH
ZINC9073

US Patents and Regulatory Information for APOKYN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Worldmeds APOKYN apomorphine hydrochloride INJECTABLE;SUBCUTANEOUS 021264-001 Apr 20, 2004 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Us Worldmeds APOKYN apomorphine hydrochloride INJECTABLE;SUBCUTANEOUS 021264-002 Apr 20, 2004 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Deloitte
Harvard Business School
Express Scripts
UBS
Accenture
Queensland Health
Chinese Patent Office
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.